Pharma BD Deal Intelligence
AbbVie Inc. / Cerevel Therapeutics
2023 · Acquisition/Merger · $8.7B · Complete
Announcement Sentiment
63
Positive
Outcome Score
31
Underwhelmed — fell short of the thesis.
AbbVie acquired Cerevel Therapeutics for $8.7B for neuroscience pipeline expansion.
Key facts
- Announced Dec 06, 2023
- Closed Aug 01, 2024
- Deal value $8.7B
- Deal type Acquisition/Merger
- Therapeutic area Neurology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals